Pharmacological clearance of senescent cells improves survival and recovery in aged mice following acute myocardial infarction.

ABSTRACT: Cardiovascular disease is the leading cause of death in individuals over 60 years old. Aging is associated with an increased prevalence of coronary artery disease and a poorer prognosis following acute myocardial infarction (MI). With age, senescent cells accumulate in tissues, including the heart, and contribute to age-related pathologies. However, the role of senescence in recovery following MI has not been investigated. In this study, we demonstrate that treatment of aged mice with the senolytic drug, navitoclax, eliminates senescent cardiomyocytes and attenuates profibrotic protein expression in aged mice. Importantly, clearance of senescent cells improved myocardial remodelling and diastolic function as well as overall survival following MI. These data provide proof-of-concept evidenc

SUBMITTER: Walaszczyk A 

PROVIDER: S-EPMC6516151 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature